bloodretin
barrier
brb
analog
bloodbrain
barrier
maintain
homeostasi
retina
restrict
entri
bloodborn
protein
retina
maintain
strict
ionic
metabol
gradient
barrier
break
excess
fluid
accumul
retina
result
macular
edema
associ
ischem
retinopathi
includ
diabet
retinopathi
dr
retinopathi
prematur
rop
ocular
inflammatori
diseas
retin
degen
diseas
varieti
ocular
disord
follow
ocular
surgeri
brb
breakdown
occur
inner
brb
establish
retin
vasculatur
outer
brb
consist
retin
pigment
epitheli
rpe
cell
site
brb
establish
format
tight
junction
retin
vascular
endotheli
rve
cell
rpe
cell
pauciti
endocyt
vesicl
within
cell
establish
mainten
brb
regul
perivascular
astrocyt
pericyt
mechan
regul
entir
clear
studi
shown
cell
cell
contact
necessari
establish
maintain
brb
other
provid
evid
solubl
mediat
suffici
brb
breakdown
result
disrupt
tight
junction
compos
complex
network
junction
protein
upregul
vesicular
transport
across
rve
rpe
degen
chang
barrierform
cell
regulatori
cell
pericyt
glia
case
brb
breakdown
relat
identifi
structur
defect
loss
pericyt
astrocyt
rpe
cell
chang
vascular
endotheli
cell
would
caus
microaneurysm
format
case
retin
vascular
leakag
diffus
uveiti
leakag
remot
lesion
surgic
wound
tumor
clear
diffus
factor
involv
bloodtissu
barrier
exist
retina
brain
nerv
vascular
endotheli
cell
choroid
tissu
fenestr
figur
allow
larg
molecular
weight
molecul
freeli
pass
blood
tissu
thu
barrier
function
tight
junction
zonula
occluden
consist
complex
arrang
protein
peripher
cytoplasm
apic
plasma
membran
connect
rve
rpe
cell
restrict
flow
figur
b
occludin
claudin
isoform
form
junction
strand
believ
constitut
backbon
tight
junction
span
plasma
membran
bind
junction
protein
adjac
cell
zonula
occluden
protein
intracellular
protein
associ
cytoplasm
surfac
tight
junction
organ
complex
bind
occludin
establish
tight
junction
integr
compon
junction
complex
junction
adhes
molecul
tricellulin
cingulin
symplekin
breach
tight
junction
figur
c
result
alter
content
junction
protein
redistribut
phosphoryl
occludin
content
tight
junction
higher
cell
tighter
barrier
decreas
occludin
correl
increas
brb
permeabl
occludin
knockout
mice
appear
form
function
tight
junction
associ
complex
simpli
regul
occludin
increas
occludin
phosphoryl
also
associ
increas
brb
permeabl
alter
express
claudin
lead
chang
select
junction
appear
particularli
import
mainten
function
tight
junction
adenosin
prostaglandin
tumor
necrosi
factora
tnfa
vascular
endotheli
growth
factor
vegf
appear
capabl
caus
morpholog
function
open
rve
tight
junction
signific
number
interendotheli
cell
tight
junction
appear
open
along
entir
length
within
h
intravitr
inject
agent
rabbit
tnfa
show
greatest
effect
interendotheli
cell
junction
appear
open
morpholog
effect
tight
junction
appear
transient
vegf
partial
revers
h
effect
adenosin
agonist
nethylcarboxamidoadenosin
revers
h
demonstr
immunoreact
albumin
would
normal
confin
lumen
vessel
bloodtissu
barrier
along
entir
length
junction
lumin
ablumin
surfac
suggest
also
function
open
figur
c
sinc
tight
junction
restrict
flow
molecul
across
brb
seri
pump
channel
transport
molecul
necessari
transport
specif
essenti
molecul
blood
retina
nonspecif
transport
high
molecular
weight
molecul
fluid
across
rve
way
pinocytot
vesicl
figur
caveola
refer
vesicular
transport
figur
b
serv
transcellular
mean
brb
breakdown
mechan
appear
predomin
mean
brb
compromis
associ
vegfainduc
hyperperm
monkey
dr
human
rat
rabbit
addit
caus
open
interendotheli
cell
tight
junction
retina
adenosin
tnfa
vegf
also
promot
format
pinocytot
vesicl
rve
cell
distribut
albumincontain
intraendotheli
vesicl
across
entir
rve
cell
lumin
ablumin
surfac
suggest
activ
vesicular
transport
occur
although
infrequ
seen
vesiculovacuolar
organel
associ
vegf
vascular
endothelium
tumor
also
evid
rve
vegftreat
rabbit
monkey
like
play
role
vegfmedi
vascular
permeabl
effect
mediat
outer
brb
less
clear
inflamm
associ
brb
breakdown
dr
choroid
neovascular
cnv
associ
agerel
macular
degener
age
ocular
inflammatori
diseas
administr
proinflammatori
molecul
increas
adhes
leukocyt
endotheli
cell
retina
associ
increas
express
intercellular
adhes
vascular
cell
adhes
adhes
molecul
upregul
vegf
proinflammatori
molecul
dr
ocular
disord
appear
regul
least
part
protein
kinas
c
pkc
diabet
knockout
mice
significantli
fewer
adher
leukocyt
diabet
mice
normal
decreas
leukostasi
associ
fewer
damag
endotheli
cell
reduc
brb
breakdown
support
role
adhes
molecul
increas
inflamm
correl
inflammatori
respons
endotheli
cell
damag
permeabl
clear
whether
molecul
facilit
leukostasi
also
mediat
brb
breakdown
attribut
molecul
secret
recruit
leukocyt
appear
direct
correl
increas
leukostasi
vascular
permeabl
retina
proinflammatori
molecul
tnfa
among
potent
induc
brb
breakdown
leukocyt
adhes
diabet
vascular
endothelium
promot
endotheli
apoptosi
inhibit
leukocyt
adhes
retin
vessel
prevent
endotheli
degener
also
reduc
diabetesassoci
loss
pericyt
support
vascular
endothelium
help
confer
brb
integr
inflamm
also
alter
distribut
astrocyt
ensheath
retin
vessel
lead
alter
brb
integr
leukocyt
also
shown
caus
downregul
redistribut
tight
junction
protein
lead
disrupt
tight
junction
transient
breakdown
brb
retin
inflamm
induct
brb
breakdown
complex
process
mediat
singl
factor
interact
multipl
factor
oper
differ
receptor
signal
pathway
list
molecul
identifi
play
role
brb
breakdown
mean
allinclus
includ
vegf
hypoxiaindic
placent
growth
factor
plgf
tnfa
plateletactiv
factor
adenosin
histamin
prostaglandin
plateletderiv
growth
factor
b
pdgfa
b
insulinlik
growth
pselectin
eselectin
key
determin
initi
event
event
part
result
cascad
target
appropri
molecul
subsequ
event
lead
brb
failur
may
block
variou
isoform
vegf
plgf
member
vegf
famili
vegfa
potent
induc
vascular
permeabl
bind
vegf
fmslike
tyrosin
kinas
insert
domaincontain
receptor
refer
kdr
human
speci
receptor
wherea
plgf
bind
compar
activ
may
mean
dissect
respect
role
vegf
receptor
isoform
sinc
receptor
implic
brb
breakdown
signal
appear
oper
primarili
mapk
mitogenactiv
protein
kinas
signal
may
mediat
ra
phosphoinositid
akt
phospholipas
c
plc
g
interact
complex
much
remain
learn
interact
receptor
associ
vascular
permeabl
angiogenesi
circumst
act
neg
regul
vegf
key
molecul
promot
increas
retin
vascular
permeabl
activ
may
mediat
least
part
upregul
eselectin
pselectin
mean
facilit
proinflammatori
activ
vegfinduc
permeabl
show
biphas
pattern
rapid
transient
phase
follow
delay
sustain
phase
latter
block
antibodi
urokinas
plasminogen
activ
receptor
vegf
receptor
kinas
inhibitor
suppress
vegfmedi
brb
breakdown
strategi
show
tnfa
induc
brb
leakag
induct
vegf
indic
mediat
oper
distinct
pathway
may
also
target
endotheli
nitric
oxid
synthas
activ
format
also
appear
implic
vegfmedi
vascular
permeabl
probabl
activ
serinethreonin
protein
kinas
akt
pkb
lead
increas
nitric
oxid
product
upregul
delet
hypoxia
respons
element
veg
f
promot
also
suppress
brb
breakdown
oxygeninduc
ischem
retinopathi
demonstr
hifinduc
vegf
critic
process
tnfa
upregul
dr
ischem
retinopathi
well
ocular
inflammatori
diseas
molecul
associ
increas
leukostasi
brb
breakdown
shown
acceler
apoptosi
retin
capillari
endotheli
cell
activ
nuclear
factor
kappa
lightchain
enhanc
activ
b
cell
exacerb
high
glucos
also
stimul
product
reactiv
oxygen
speci
turn
induc
releas
addit
cytokin
aspirin
etanercept
inhibitor
tnfa
reduc
level
diabetesrel
leukostasi
brb
breakdown
diabet
rat
without
alter
vegf
level
show
tnfa
involv
process
oper
distinct
pathway
vegf
data
show
number
potenti
target
molecul
inhibitor
suppress
brb
breakdown
challeng
identifi
best
target
target
develop
effect
therapeut
strategi
varieti
method
exist
quantit
qualit
assess
brb
method
particular
limit
sensit
choic
method
larg
depend
whether
quantit
qualit
data
desir
natur
tissu
evalu
whether
fix
tissu
patient
clinic
set
experiment
anim
model
sinc
singl
method
provid
quantit
assess
precis
local
site
brb
breakdown
multipl
approach
may
necessari
provid
overal
perspect
addit
method
produc
precis
data
experiment
model
tissu
specimen
appropri
use
clinic
identifi
compar
factor
caus
brb
breakdown
evalu
efficaci
new
treatment
design
prevent
reduc
macular
edema
reliabl
quantit
assay
assess
brb
function
essenti
wide
use
protocol
quantit
assess
brb
breakdown
util
evan
blue
tracer
evan
blue
assay
extract
dye
quantifi
retina
follow
intraven
inject
dye
subsequ
perfus
salin
spectrophotomet
set
nm
use
quantifi
leakag
dye
retina
assay
scintil
counter
use
determin
cpmmg
tissu
h
intraperiton
inject
tracer
data
express
ratio
retinalung
retinakidney
sinc
lung
kidney
bloodtissu
barrier
ratio
correct
variat
amount
isotop
inject
absorb
method
use
assess
brb
sever
model
ocular
diseas
determin
effect
variou
factor
agent
genet
manipul
integr
brb
thu
method
use
identifi
factor
initi
brb
compromis
determin
rel
efficaci
variou
agent
prevent
reduc
brb
failur
method
produc
highli
reproduc
result
experiment
set
assay
possibl
somewhat
sensit
due
lower
molecular
weight
mannitol
evan
blue
dye
neither
applic
clinic
vitreou
fluorophotometri
vfp
appropri
mean
assess
brb
failur
clinic
set
although
method
provid
quantit
assess
brb
local
site
leakag
provid
insight
mechan
altern
techniqu
requir
provid
inform
fluorescein
angiographi
use
extens
clinic
visual
brb
breakdown
allow
resolut
cellular
level
magnet
reson
imag
mri
enhanc
paramagnet
contrast
agent
gandoliniumdiethylenetriaminetetraacet
acid
use
local
quantifi
brb
breakdown
live
anim
mri
subject
optic
limit
vfp
allow
investig
distinguish
inner
outer
brb
failur
rabbit
resolut
great
result
microscop
evalu
fix
tissu
mri
allow
vivo
analysi
thu
enabl
investig
monitor
progress
chang
brb
integr
within
anim
use
exogen
tracer
substanc
provid
higher
resolut
sever
limit
associ
use
use
tracer
impract
clinic
studi
introduct
exogen
materi
may
alter
brb
integr
retrospect
studi
done
archiv
tissu
immunoloc
endogen
albumin
figur
igg
circumv
limit
offer
follow
advantag
brb
assess
techniqu
use
fix
surgic
autopsi
archiv
specimen
exogen
substanc
introduc
use
light
electron
microscop
em
level
although
natur
quantit
method
show
locat
extent
brb
breakdown
use
em
level
demonstr
mean
serum
protein
extravas
retin
vessel
may
transvers
rpe
layer
techniqu
use
assess
brb
varieti
human
experiment
ocular
disord
includ
dr
retin
pigmentosa
vascular
occlus
diseas
neoplast
diseas
ocular
inflamm
infect
diseas
develop
macular
edema
patholog
defect
reveal
caus
brb
breakdown
em
immunocytochem
stain
albumin
reveal
brb
breakdown
occur
open
tight
junction
rve
rpe
cell
figur
c
upregul
transendotheli
vesicular
transport
figur
b
increas
surfac
membran
permeabl
rve
rpe
cell
result
degen
chang
associ
diseas
process
also
provid
insight
variou
factor
vegf
tnfa
prostaglandin
adenosin
other
promot
brb
breakdown
vegf
transient
open
tight
junction
leakag
interendotheli
cell
tight
junction
induc
vegf
electron
microscopi
reveal
predomin
mechan
vegfainduc
hyperperm
rve
monkey
diabetesrel
brb
breakdown
human
rabbit
rat
upregul
pinocytot
vesicular
transport
c
immunohistochem
stain
red
show
albumin
leak
retin
vessel
vegf
transgen
mous
vinor
et
al
bloodretin
barrier
breakdown
experiment
coronaviru
retinopathi
associ
viral
antigen
inflamm
vegf
sensit
resist
strain
journal
neuroimmunolog
permiss
elsevi
varieti
therapeut
approach
shown
success
inhibit
brb
breakdown
gener
prevent
agent
current
clinic
trial
target
inflammatori
process
vegf
antibodi
key
molecul
vegf
plgf
tnfa
effect
suppress
brb
breakdown
inhibitor
molecul
drug
block
histamin
receptor
also
reduc
retin
vascular
leakag
diabet
rat
human
bevacizumab
avastin
antivegf
antibodi
ranibizumab
lucenti
fab
fragment
human
antivegf
antibodi
pegaptanib
sodium
macugen
vegf
aptam
vegf
trap
bind
domain
combin
fc
portion
igg
neutral
vegf
famili
member
shown
vari
degre
success
clinic
trial
reduc
macular
edema
target
vegf
corticosteroid
inhibit
brb
breakdown
clear
whether
activ
mediat
antiinflammatori
effect
occur
least
part
downregul
inhibit
vegf
express
induct
occludin
express
revers
occludin
phosphoryl
combin
activ
even
though
steroid
may
improv
visual
acuiti
carri
high
risk
cataract
glaucoma
involv
pkc
vascular
permeabl
establish
pkc
activ
promot
brb
breakdown
pkc
inhibitor
reduc
retin
vascular
permeabl
particularli
mediat
vegf
prostaglandin
gener
inhibit
pkc
like
seriou
system
consequ
pkcb
inhibitor
also
effect
suppress
retin
vascular
permeabl
may
fewer
complic
studi
conduct
complex
brb
breakdown
lead
macular
edema
becom
increasingli
appar
process
attribut
singl
factor
event
interact
undetermin
number
initi
event
gener
cascad
subsequ
event
ultim
lead
brb
failur
sinc
multifactori
process
multifacet
pleiotrop
approach
restor
homeostat
balanc
like
suppress
brb
breakdown
target
singl
pathway
inhibitor
would
explain
current
use
monotherapi
may
lead
reduct
macular
edema
improv
visual
acuiti
gener
total
resolut
disord
develop
effect
therapeut
strategi
better
understand
basic
mechan
pathogenesi
brb
breakdown
imper
addit
frequent
inject
high
cost
occasion
side
effect
associ
current
therapeut
approach
emphas
need
effect
treatment
less
invas
less
costli
littl
side
effect
brb
breakdown
lead
macular
edema
occur
number
ocular
disord
due
structur
chang
solubl
mediat
alter
content
distribut
phosphoryl
junction
protein
result
vascular
leakag
tight
junction
brb
breakdown
also
result
upregul
transendotheli
vesicular
transport
shown
major
contributor
brb
failur
caus
sever
mediat
ocular
diseas
model
mani
mediat
simultan
promot
open
tight
junction
upregul
vesicular
transport
degen
structur
chang
rpe
rve
cell
pericyt
perivascular
astrocyt
regul
inner
brb
also
lead
brb
breakdown
inflamm
promot
brb
breakdown
use
antiinflammatori
agent
may
benefici
brb
breakdown
due
singl
factor
complex
process
involv
multipl
factor
receptor
signal
pathway
inform
molecular
mechan
reveal
much
remain
learn
complex
pathogenesi
brb
breakdown
make
like
greatest
chanc
success
prevent
macular
edema
would
target
multipl
molecul
pathway
sensit
method
assess
integr
brb
necessari
monitor
efficaci
differ
therapeut
strategi
